Ancora.ai logo

Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials.

9 employees · est. 2017 · Zurich, Switzerland

VS
Oncoshot logo

Oncoshot

Made to connect cancer patients, hospitals, and industry with real-time insights.

20 employees · est. 2018 · Singapore, Singapore

Ancora.ai is the older company (2017 vs 2018); Oncoshot is the larger of the two.

Side-by-Side Comparison

Ancora.ai Oncoshot
Founded
2017 older 2018
Headquarters
Zurich, Switzerland Singapore, Singapore
Employees
9 20 larger
Industry
AI, Big Data, Health Care Digital Health, Health Care, Information Technology
Funding Stage
Grant Seed
Total Funding
$465.00K $2.90M
Funding Rounds
6 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
AI-driven, Digital Clinical Trials, Precision Medicine, Patient Centricity, Health Equity, Oncology, Cancer, Neural Networks, Deep Learning, Personalized Medicine, NLP, Clinical Trial Recruitment Clinical Trials, Oncology, Data Science, Cancer Care, Patient Empowerment, Global Healthcare, Healthcare Regulations, Health Data Exchange, Patient-centric Solutions
Website
ancora.ai oncoshot.com
Ancora.ai logo

About Ancora.ai

Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes,...

Oncoshot logo

About Oncoshot

Oncoshot is a health insights exchange platform founded in 2018 in Singapore with the slogan "Made to connect cancer patients, hospitals, and industry with real-time insights." Founded by Medical Oncologist Dr Huren Sivaraj and Data Science Engineer Ruslan Enikeev, the startup leverages its propriet...

We will tell you when either one moves

BounceWatch watches Ancora.ai and Oncoshot for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ancora.ai and Oncoshot — by email.

Frequently Asked Questions

Ancora.ai — Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials. . Oncoshot — Made to connect cancer patients, hospitals, and industry with real-time insights.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ancora.ai has raised $465.00K while Oncoshot has raised $2.90M.
Ancora.ai and Oncoshot operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ancora.ai with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Ancora.ai on 11 Sep 2024, and Oncoshot on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy